As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest Risk

Washington’s campaign to keep cutting-edge technology out of China took a new twist late last week with the addition of Chinese medical companies to U.S. blacklists Key takeaways: Washington has blacklisted 37 medical-related companies, most of them Chinese, over concerns their skills and technology could be used to help the Chinese military Shares of companies that develop their own drugs are coming under more pressure than peers who license drugs from third-parties following the move   By Doug Young In these troubled times of U.S.-China tensions, sometimes being a copycat has…

Read More »